Fusion event
HBV-DPY19L2P3 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Region type
precore/core protein|
Integrated sequence
CTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGG| |GCATGGACATCGACCCTTATAAAGAATTTGGAGCTACTGTGGAGTTACTCTCGTTTTTGCCTTCTGACTTCTTTCCTTCAGTACGAGATCTTCTAGATAC
End
29778797/29739181 (Hg38)
Nearest miRNA
hsa-mir-1183/Upstream/58353; hsa-mir-10399/Downstream/550613;
Upstream sequence
CCAAAGAGCTCCTAGAAAATAAAGACAAAGCCTAAGGATCAGATACATCTTGAGACTGATAGAGAATTCCAGAAGTTTCTCTCCTTCAGTACTTTATTGT
Downstream sequence
tgtgcaagtggagtttatcccaggaatgcaaagttgtctcactatttgaaaaccaatcaggtgaattcaccacagtaacaaactgaaaaagaaagaccgc
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.